Fulgent Genetics, Inc. (FLGT) vs Exagen Inc. (XGN)
- Fulgent Genetics, Inc. FLGT 19.81 −7.17%
- Exagen Inc. XGN 7.65 −10.63%
Fulgent Genetics, Inc. and Exagen Inc. are both Diagnostics & Research companies. Fulgent Genetics, Inc. is the larger, with a market value of $587.2M against $207.4M — 2.8× the size. Exagen Inc. grew revenue faster over the last twelve months: 20.8% against 6.83%. Fulgent Genetics, Inc. has the higher net margin (−26.1% vs −26.6%) and the higher return on invested capital (−10.3% vs −68.3%). Across the 18 metrics below, Fulgent Genetics, Inc. leads on 9 and Exagen Inc. on 9.
Valuation
Profitability
| Metric | FLGT | XGN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 35.58% | 58.64% | 50.89% |
| Operating margin | (37.75%) | (18.58%) | (8.57%) |
| Net margin | (26.05%) | (26.61%) | (6.37%) |
| Free cash flow margin | (32.04%) | (10.66%) | 0.00% |
| Return on equity | (8.01%) | (113.82%) | (2.92%) |
| Return on assets | (7.37%) | (34.19%) | (6.71%) |
| Return on invested capital | (10.34%) | (68.33%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack